AstraZeneca consolidates its drug development work

03/19/2013 | Reuters · USA Today

AstraZeneca plans to restructure its research and development operations to bring together drug development activities in three major facilities in the U.S., England and Sweden. A Gaithersburg, Md., facility will become the main hub for biotech research. The changes, meant to cut costs and increase productivity, will eliminate about 1,600 positions.

View Full Article in:

Reuters · USA Today

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
President/Chief Executive Officer
MedCost
Winston-Salem, NC
Consumer Directed Health Plan (CDH) Product Offering Manager
Blue Cross Blue Shield MA
Quincy, MA
Director, Payer Marketing
Avalere Health
Washington, DC
Actuary
Meridian Health Plan
Detroit, MI
Chief Medical Officer, Texas Children's Health Plan
Cejka Executive Search for Texas Childre's Health Plan
Houston, TX